SMYD2 and colonic neoplasm: To exclude the possibility of off-target effects of AZ505 or murine cell specific effects, we used BAY-598, an alternative SMYD2 inhibitor that has a different binding mode compared to AZ505 [32, 33], to further investigate the impact of SMYD2 inhibition in human colon tumor growth.